MAP2K7 and cholangiocarcinoma: For example, TTYH3 has been shown to facilitate bladder cancer through the FGFR1/H‐Ras/A‐Raf/MEK/ERK pathway,15 and its upregulation promotes EMT in cholangiocarcinoma.27